SKI Market

Indian Indices

Nifty

26,013.45 103.40
(0.40%)

Sensex

84,863.24 -87.71
( -0.10%)

Bank Nifty

58,962.70 445.15
( 0.76%)

Nifty IT

36,375.20 73.95
( 0.20%)

Global Indices

Nasdaq

46,604.53 -563.95
(-1.20%)

Dow Jones

6,692.71 -62.40
(-0.92%)

Hang Seng

50,246.57 -129.96
(-0.26%)

Nikkei 225

9,695.49 -2.88
(-0.03%)

Forex

USD-INR

88.65 -0.06
(-0.07%)

EUR-INR

103.02 -0.02
(-0.02%)

GBP-INR

116.73 0.00
(0.00%)

JPY-INR

0.57 0.00
(-0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bajaj Healthcare Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

539872

INE411U01027

154.0035922

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BAJAJHCARE

27.28

1396.77

EPS(TTM)

Face Value()

Div & Yield %

16.21

0.23

Back

sanwaria consumer ltd

Dabur India consolidated net profit rises 6.48% in the September 2025 quarter

Oct 30,2025

Net profit of Dabur India rose 6.48% to Rs 452.55 crore in the quarter ended September 2025 as against Rs 425.00 crore during the previous quarter ended September 2024. Sales rose 5.37% to Rs 3191.32 crore in the quarter ended September 2025 as against Rs 3028.59 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	3191.32	3028.59	5
OPM %	18.42	18.24	-
PBDT	688.42	656.92	5
PBT	573.02	545.95	5
NP	452.55	425.00	6

26,013.45 103.40 (0.40%)

84,863.24 -87.71 ( -0.10%)

58,962.70 445.15 ( 0.76%)

36,375.20 73.95 ( 0.20%)

46,604.53 -563.95 (-1.20%)

6,692.71 -62.40 (-0.92%)

50,246.57 -129.96 (-0.26%)

9,695.49 -2.88 (-0.03%)

88.65 -0.06 (-0.07%)

103.02 -0.02 (-0.02%)

116.73 0.00 (0.00%)

0.57 0.00 (-0.02%)